These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8189133)

  • 1. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
    Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
    J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Langer A; Krucoff MW; Klootwijk P; Veldkamp R; Simoons ML; Granger C; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1995 Jun; 25(7):1552-7. PubMed ID: 7759706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
    Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 5. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
    Barbagelata A; Califf RM; Sgarbossa EB; Knight D; Mark DB; Granger CB; Armstrong PW; Elizari M; Birnbaum Y; Grinfeld LR; Ohman EM; Wagner GS;
    Am Heart J; 2004 Nov; 148(5):795-802. PubMed ID: 15523309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 8. An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
    Kent DM; Hayward RA; Griffith JL; Vijan S; Beshansky JR; Califf RM; Selker HP
    Am J Med; 2002 Aug; 113(2):104-11. PubMed ID: 12133748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.
    Holmes DR; Califf RM; Topol EJ
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):10S-17S. PubMed ID: 7775708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction.
    Birnbaum Y; Herz I; Sclarovsky S; Zlotikamien B; Chetrit A; Olmer L; Barbash GI
    J Am Coll Cardiol; 1996 Aug; 28(2):313-8. PubMed ID: 8800103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
    Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ;
    Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Lee KL; Califf RM; Simes J; Van de Werf F; Topol EJ
    Ann Intern Med; 1994 May; 120(10):876-81; discussion 882-5. PubMed ID: 8154647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R; Fattore G; Gensini G
    G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
    Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
    Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the GUSTO trial's main conclusion--author's reply. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Stringer KA
    Pharmacotherapy; 1997; 17(5):1043. PubMed ID: 9324198
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Friedman HS
    N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
    [No Abstract]   [Full Text] [Related]  

  • 19. The place of thrombolysis in the management of cerebral embolism after heart valve replacement.
    Wardlaw JM
    J Heart Valve Dis; 1994 Nov; 3(6):611-2. PubMed ID: 8000603
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous vectorcardiography is superior to standard electrocardiography in the prediction of long-term outcome after thrombolysis in patients with acute myocardial infarction.
    Gill S; Haastrup B; Haghfelt T; Dellborg M; Clemmensen P
    Coron Artery Dis; 2002 May; 13(3):169-75. PubMed ID: 12131021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.